| Term 
 | Definition 
 
        | The study of substances that interact with living systems through chemical processes |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | deals with the undesirable effects of chemicals on living systems |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | study of the biochemical and physiologic effect of drugs and their mechanism of action the actions of the drug on the body  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | the actions of the body on the drug involves absorption, dirstribution, metabolism, and elimination (ADME) |  | 
        |  | 
        
        | Term 
 
        | Pharmacogenomics (pharmacogenetics) |  | Definition 
 
        | the study of genetic variations that case differences in response among individulas or populations |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | insertion of appropriate "healthy" gene into cells |  | 
        |  | 
        
        | Term 
 
        | What are the three types of animal gene studies? |  | Definition 
 
        | knockout knockdown knockin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | bread to have homozygoously complete suppression of studied function |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | limited suppression of the function |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | over expression of proteins of interest |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | component of a cell or organism that interacts with a drug initiated the chain of biochemical events leading to the drug's observed effect plays a regulatory role in the drug molecular interaction with specific molecules in the biological system |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | molecule that binds to a receptor involved in chemcial signaling |  | 
        |  | 
        
        | Term 
 
        | What are examples of ligands? |  | Definition 
 
        | neurtransmitter hormone drug messenger molecule |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | drug that is synthesized within the body |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | drug that is made of chemical oustide of the body |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | poisons of biological origin harmful effects |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | drugs bind to an activate the receptor directly or indirectly brings about the effect |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | binds to the receptor and prevents binding by other molecules |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | the penetration of a permeate(liguid, gas, or vapor) through a solid |  | 
        |  | 
        
        | Term 
 
        | what are types of permeation? |  | Definition 
 
        | aqueous diffusion lipid diffusion transport by special carriers endocytosis and exocytosis |  | 
        |  | 
        
        | Term 
 
        | What is aqueous diffusion? |  | Definition 
 
        | occurs within the larger aqueous compartemtns of the body across epithelial membrane junctions through aqueous pores of the endothelial lining of blood vessels governed by Fick's Law |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | most important limiting factor for drug permeation is the lipid barriers the ability to move from aqueous to lipid (or lipid to aqueous) vares on the pH of the medium governed by Fick's law |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | exist for certain substances that are important for cell function may be too large to diffuse passively through the membrane not governed by Fick's law and is capactiy-limited |  | 
        |  | 
        
        | Term 
 
        | what types of permeation are governed by Fick's Law? |  | Definition 
 
        | Aqueous diffusion lipid diffusion |  | 
        |  | 
        
        | Term 
 
        | what are exampls of speical carriers? |  | Definition 
 
        | amino acids carriers in teh BBB weak acid carriers in renal tubules |  | 
        |  | 
        
        | Term 
 
        | Speical Carriers: Multidurg-resistance type 1 transporter |  | Definition 
 
        | MDR1 also known as P-glycoprotien found in brain, testes, many neoplastic cells and other tissues cancer drug resistance in GI tract epithelium |  | 
        |  | 
        
        | Term 
 
        | Multidrug resistance-associated protein transporters (MRP1-MRP5) |  | Definition 
 
        | important role in excreation of some drugs/metabolites into the urine and bile uptake of neurotransmitters across nerve ending membranes |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | substance is too large, lipid-insoluble or impermeant to the cell the process by which the substance is engulfed by the cell membrane and carried into the cell by pinching off of the newly formed vesicle inside the membrane content of resulting vesicle are release into the cytoplasm of cell |  | 
        |  | 
        
        | Term 
 
        | what are examples of endocytosis? |  | Definition 
 
        | B12 with intrinsic factor Iron with transferrin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | process bu which a cell directs the contents of secretory vesicles out of the cell membrane, releasing a substances from the cell |  | 
        |  | 
        
        | Term 
 
        | what are exmaples of exocytosis? |  | Definition 
 
        | calcium into the blood stream enzymes from pancreatic cells hormones from endocrine glands |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | involves passive diffusion of molecualr down a concentration gradient   Flux = (C1 – C2)  x      area x permeability coefficient  thickness  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | quantifies relationships -drug absorption occurs faster from organs with large surface are vs organs with small absorbing areas -drugs absorption is faster from organs with thin membrane barriers than those with thick membranes (lungs vs. skin) |  | 
        |  | 
        
        | Term 
 
        | What are water molecules attracted to? |  | Definition 
 
        | charged drug molecules more charged= more water soluble |  | 
        |  | 
        
        | Term 
 
        | Lipid solubility of a drug relationship to charge |  | Definition 
 
        | inversely proportional more charged= less lipid solubility uncharged= more lipid soluble |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | HA ↔ H+ + A- protonated form is neutral |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   RNH3+  ↔ RNH2 + H+ unprotonated form is neutral |  | 
        |  | 
        
        | Term 
 
        | Henderson-hasselbalch protonation |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What occurs to WA and WB in different pH? |  | Definition 
 
        | more WA will be lipid soluable at acidic pH More WB will be lipd soluble at alkaline pH |  | 
        |  | 
        
        | Term 
 
        | durg elimination what type of species are found in renal and biliary elimination? |  | Definition 
 
        | renal elimination: polar species= water soluble biliary elimination: non-polar= lipid soluble |  | 
        |  | 
        
        | Term 
 
        | in excreation which (WA or WB) will be excreted faster in alkaline urine? |  | Definition 
 
        | Weak acids most drugs are freely filtered in the glomerulus but lipid-soluble drugs can be rapidly reabsorbed give bicarbonate to speed up excretion |  | 
        |  | 
        
        | Term 
 
        | Which (WA or WB) is excreted faster in acidic urine? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | component of a cell or organism that interacts with a drug and initiated the chain of biochemical events leading to the drug's observed effect |  | 
        |  | 
        
        | Term 
 
        | what largely determines the quatitative relationships between dose or concentration of drug and pharmacologic effects? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What are the three receptors properties responsible for selectivity of drug action? |  | Definition 
 
        | size shape electrical cahrge |  | 
        |  | 
        
        | Term 
 
        | What mediates the action of both pharmacologic agonsits and antagonists? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what are the functions of regulatory proteins? |  | Definition 
 
        | mediated the actions of endogenous chemical signals mediates the effects of many of the most useful therpeutic agents |  | 
        |  | 
        
        | Term 
 
        | What are orphan receptors? |  | Definition 
 
        | have unknown ligands   (receptors are being discovered based on perdicted structure or likeness to already known receptors drugs that bind to them are developed accordingly) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | may be inhibited or activated by binding to a drug   examples: dihydrofolate reductase is targeted by methotrexate (MTX) |  | 
        |  | 
        
        | Term 
 
        | What are transport proteins? |  | Definition 
 
        | portein involved in the movement of a chemical across a biological membrane   example: Na/K ATPase is the membrane recceptor for digoxin |  | 
        |  | 
        
        | Term 
 
        | what are structural proteins? |  | Definition 
 
        | those proteins with the primary purpose of producing the essential structural components   example: tubulin is the receptor for colchicine |  | 
        |  | 
        
        | Term 
 
        | equation for drug concentration and response |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | the concentration of drug that produces 50% of maximal effect |  | 
        |  | 
        
        | Term 
 
        | drug receptor and effect relationship equation |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | equilibrium constant concentration of free drug at which half maximal binding is observed |  | 
        |  | 
        
        | Term 
 
        | what does the response produced by a agonist depends on two factors? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | how well binds to the receptor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | how well it causes a response once bound |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | produces a full response at full receptor occupancy |  | 
        |  | 
        
        | Term 
 
        | what is a patial agonist? |  | Definition 
 
        | produces a lower response at full receptor occupancy response similar to that when a competitive antagonsit irreversibly blocks some of the receptos sites |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | readily dissociate from their receptor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | form a permanent, irreversible (or nearly irreversible) chemical bond with their receptor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | binds to the receptor and prevents binding of the agonist (bind to the same site) does NOT activate it |  | 
        |  | 
        
        | Term 
 
        | noncompetitive antagonsit |  | Definition 
 
        | can be bound simultaneously with agonist but reduces/ prevents action of agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ionically binds to drugs to make it unavailable for interaction with receptors or other substances   examples: protamine (positively charged) binds to heparin (negatively charged) to reverse/stop anticoagulant effects of heparin |  | 
        |  | 
        
        | Term 
 
        | pharmacological antagonist |  | Definition 
 
        | produces action at teh same site as agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | produces the opposite effect of the agonist through a different receptor |  | 
        |  | 
        
        | Term 
 
        | What are the different types of transmembrane signaling? |  | Definition 
 
        | 1. Lipid soluble 2. extracellular 3. extracellular domain 4. Direct binidng 5. binidng via G proteins |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | chemical signal crossed the plasma membrane acts on an intracellular receptor |  | 
        |  | 
        
        | Term 
 
        | extracellular transmembrane signal |  | Definition 
 
        | signal binds to extracellular domain of the transmembrane protein activated an enzymatic activity of its cytoplasmic domain substrate A results in Product B |  | 
        |  | 
        
        | Term 
 
        | extracellular domain transmembrane signaling |  | Definition 
 
        | signal binds to an extracellular domain of a transmembrane receptor the transmembrane receptor is bound to a protein tyrpsine kinase the protein tyrosine kinase is activated |  | 
        |  | 
        
        | Term 
 
        | direct binding transmembrane signaling |  | Definition 
 
        | signal binds directly to the ion channel ion channel is opend and regulated directly by the signal |  | 
        |  | 
        
        | Term 
 
        | binding via G proteins transmembrane signaling |  | Definition 
 
        | signal binds to cell-surface receptor cell-surface receptor is linked to a G protein G protein is linked to an effector enzyme  (enzyme or ion channel) the effector enzyme converts substrate into product |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | receptors are considered "spare" when a given biological response is maximized, despite a concentration of agonist that does not occupy all available receptors |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | process by normal cell receptor degradation exceeds the synthesis of new receptors end result is less receptors to activate |  | 
        |  |